1,665 Shares in Intuitive Surgical, Inc. $ISRG Acquired by Pincus Capital Management LP

Pincus Capital Management LP bought a new position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRGFree Report) in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund bought 1,665 shares of the medical equipment provider’s stock, valued at approximately $943,000. Intuitive Surgical comprises 0.6% of Pincus Capital Management LP’s investment portfolio, making the stock its 29th biggest holding.

Several other institutional investors have also recently added to or reduced their stakes in the business. Riversedge Advisors LLC lifted its stake in Intuitive Surgical by 1.9% in the fourth quarter. Riversedge Advisors LLC now owns 901 shares of the medical equipment provider’s stock valued at $510,000 after buying an additional 17 shares during the last quarter. Fiduciary Financial Group LLC lifted its stake in Intuitive Surgical by 2.1% in the fourth quarter. Fiduciary Financial Group LLC now owns 920 shares of the medical equipment provider’s stock valued at $521,000 after buying an additional 19 shares during the last quarter. Prosperity Consulting Group LLC lifted its stake in Intuitive Surgical by 0.5% in the third quarter. Prosperity Consulting Group LLC now owns 4,033 shares of the medical equipment provider’s stock valued at $1,804,000 after buying an additional 19 shares during the last quarter. Sunburst Financial Group LLC lifted its stake in Intuitive Surgical by 4.3% in the fourth quarter. Sunburst Financial Group LLC now owns 485 shares of the medical equipment provider’s stock valued at $275,000 after buying an additional 20 shares during the last quarter. Finally, WoodTrust Financial Corp lifted its stake in Intuitive Surgical by 0.5% in the fourth quarter. WoodTrust Financial Corp now owns 4,180 shares of the medical equipment provider’s stock valued at $2,367,000 after buying an additional 20 shares during the last quarter. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Intuitive Surgical Price Performance

Shares of ISRG stock opened at $412.26 on Tuesday. The business’s fifty day moving average price is $452.19 and its 200 day moving average price is $504.81. Intuitive Surgical, Inc. has a 1-year low of $411.83 and a 1-year high of $603.88. The firm has a market capitalization of $146.01 billion, a PE ratio of 49.97, a P/E/G ratio of 3.39 and a beta of 1.46.

Intuitive Surgical (NASDAQ:ISRGGet Free Report) last announced its quarterly earnings data on Tuesday, April 21st. The medical equipment provider reported $2.50 earnings per share for the quarter, topping analysts’ consensus estimates of $2.08 by $0.42. Intuitive Surgical had a return on equity of 15.98% and a net margin of 28.15%.The firm had revenue of $2.77 billion for the quarter, compared to analyst estimates of $2.62 billion. During the same quarter in the prior year, the company posted $1.81 earnings per share. Intuitive Surgical’s quarterly revenue was up 23.0% on a year-over-year basis. Equities research analysts expect that Intuitive Surgical, Inc. will post 8.57 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

A number of brokerages have weighed in on ISRG. Argus reduced their price objective on Intuitive Surgical from $630.00 to $560.00 and set a “buy” rating for the company in a research note on Wednesday, February 4th. Mizuho set a $525.00 price objective on Intuitive Surgical and gave the company a “neutral” rating in a research note on Monday, April 13th. Truist Financial reduced their price objective on Intuitive Surgical from $650.00 to $580.00 and set a “buy” rating for the company in a research note on Wednesday, April 15th. Citigroup upgraded Intuitive Surgical from a “neutral” rating to a “buy” rating and set a $590.00 price objective for the company in a research note on Wednesday, March 11th. Finally, The Goldman Sachs Group set a $558.00 price objective on Intuitive Surgical in a research note on Wednesday, May 27th. Nineteen research analysts have rated the stock with a Buy rating, seven have issued a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average target price of $576.71.

Get Our Latest Report on Intuitive Surgical

Insider Transactions at Intuitive Surgical

In other Intuitive Surgical news, Director Amy L. Ladd sold 119 shares of the company’s stock in a transaction on Wednesday, April 29th. The stock was sold at an average price of $463.50, for a total value of $55,156.50. Following the sale, the director owned 120 shares of the company’s stock, valued at approximately $55,620. This represents a 49.79% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP Gary Loeb sold 400 shares of the company’s stock in a transaction on Monday, May 11th. The shares were sold at an average price of $446.95, for a total value of $178,780.00. Following the completion of the sale, the executive vice president directly owned 6,120 shares in the company, valued at $2,735,334. This trade represents a 6.13% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 4,833 shares of company stock worth $2,357,582 over the last ninety days. 0.60% of the stock is currently owned by company insiders.

Intuitive Surgical Company Profile

(Free Report)

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.

Read More

Institutional Ownership by Quarter for Intuitive Surgical (NASDAQ:ISRG)

Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.